D-Index & Metrics Best Publications
Microbiology
Netherlands
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 82 Citations 20,914 294 World Ranking 282 National Ranking 8
Medicine D-index 76 Citations 17,694 323 World Ranking 11332 National Ranking 370

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Netherlands Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Virus

His primary areas of investigation include Aspergillus fumigatus, Microbiology, Aspergillosis, Polymerase chain reaction and Virology. In his study, Voriconazole is inextricably linked to Itraconazole, which falls within the broad field of Aspergillus fumigatus. His Microbiology study incorporates themes from Verocytotoxin and Escherichia coli.

The concepts of his Aspergillosis study are interwoven with issues in Aspergillus, Internal medicine, Disease, Fungi imperfecti and Mycosis. He has included themes like Molecular biology, Mollicutes, Papillomaviridae and Pathology in his Polymerase chain reaction study. His Virology research includes elements of Cervical cancer and Genotype.

His most cited work include:

  • Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. (542 citations)
  • Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? (412 citations)
  • GENUS AND SPECIES- SPECIFIC IDENTIFICATION OF MYCOPLASMAS BY 16S RRNA AMPLIFICATION (370 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Microbiology, Aspergillus fumigatus, Virology, Internal medicine and Aspergillosis. The Microbiology study combines topics in areas such as Genotype, Fungal protein and Polymerase chain reaction. His work deals with themes such as Azole, Aspergillus and Itraconazole, Voriconazole, Posaconazole, which intersect with Aspergillus fumigatus.

His Virology research is multidisciplinary, incorporating perspectives in RNA and Immunology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Gynecology and Oncology. His Aspergillosis research incorporates themes from Pharmacodynamics and Azole resistance.

He most often published in these fields:

  • Microbiology (27.25%)
  • Aspergillus fumigatus (20.29%)
  • Virology (19.88%)

What were the highlights of his more recent work (between 2017-2021)?

  • Aspergillus fumigatus (20.29%)
  • Microbiology (27.25%)
  • Aspergillosis (14.96%)

In recent papers he was focusing on the following fields of study:

Willem J. G. Melchers spends much of his time researching Aspergillus fumigatus, Microbiology, Aspergillosis, Internal medicine and Cervical intraepithelial neoplasia. His studies in Aspergillus fumigatus integrate themes in fields like Itraconazole, Azole, Azole resistance, Aspergillus and Gene. His research integrates issues of Cystic fibrosis, Agar and Genotype in his study of Microbiology.

His study in Aspergillosis is interdisciplinary in nature, drawing from both Hematopoietic stem cell transplantation, Transplantation, Voriconazole and Hematological malignancy. His studies deal with areas such as Gastroenterology, Oncology and Triage as well as Internal medicine. His Cervical intraepithelial neoplasia study combines topics in areas such as Relative risk, Cytology, Colposcopy and Obstetrics.

Between 2017 and 2021, his most popular works were:

  • European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia (98 citations)
  • Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study (77 citations)
  • Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management (57 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • DNA

The scientist’s investigation covers issues in Aspergillus fumigatus, Aspergillosis, Microbiology, Aspergillus and Internal medicine. His biological study spans a wide range of topics, including RNA, Sputum, Sequence analysis and Sequence assembly. His work carried out in the field of Aspergillosis brings together such families of science as Hematopoietic stem cell transplantation, Transplantation, Cell growth, Voriconazole and Drug resistance.

His Voriconazole research includes themes of Itraconazole and Disease. His study on Azole, Antibiotic resistance and Azole resistance is often connected to Triazole as part of broader study in Microbiology. His Aspergillus study also includes fields such as

  • Immunology that intertwine with fields like In vivo,
  • Fungicide and related Clinical significance and Echinocandin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.

Eveline Snelders;Henrich A. L van der Lee;Judith Kuijpers;Anthonius J. M. M Rijs.
PLOS Medicine (2008)

692 Citations

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

Paul E Verweij;Eveline Snelders;Gert H J Kema;Emilia Mellado.
Lancet Infectious Diseases (2009)

644 Citations

A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations

E. Mellado;G. Garcia-Effron;L. Alcázar-Fuoli;W. J. G. Melchers.
Antimicrobial Agents and Chemotherapy (2007)

564 Citations

GENUS AND SPECIES- SPECIFIC IDENTIFICATION OF MYCOPLASMAS BY 16S RRNA AMPLIFICATION

F.J.M. van Kuppeveld;J.T.M. van der Logt;A.F. Angulo;M.J. van Zoest.
Applied and Environmental Microbiology (1992)

517 Citations

Multiple-triazole-resistant aspergillosis.

Paul E Verweij;Emilia Mellado;Willem J G Melchers.
The New England Journal of Medicine (2007)

469 Citations

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

Eveline Snelders;Robert A. G. Huis in 't Veld;Anthonius J. M. M. Rijs;Gert H. J. Kema.
Applied and Environmental Microbiology (2009)

456 Citations

General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections.

G. J. Zoll;W. J. G. Melchers;H. Kopecka;G. Jambroes.
Journal of Clinical Microbiology (1992)

449 Citations

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Paul E. Verweij;Anuradha Chowdhary;Willem J. G. Melchers;Jacques F. Meis.
Clinical Infectious Diseases (2016)

424 Citations

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009

Jan W. M. van der Linden;Eveline Snelders;Greetje A. Kampinga;Bart J. A. Rijnders.
Emerging Infectious Diseases (2011)

406 Citations

Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release

Frank J.M. van Kuppeveld;Joost G.J. Hoenderop;Rolf L.L. Smeets;Peter H.G.M. Willems.
The EMBO Journal (1997)

355 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Willem J. G. Melchers

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 114

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 108

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 78

David W. Denning

David W. Denning

University of Manchester

Publications: 77

Frank J. M. van Kuppeveld

Frank J. M. van Kuppeveld

Utrecht University

Publications: 76

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 69

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 65

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 54

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 53

Peter J.F. Snijders

Peter J.F. Snijders

Vrije Universiteit Amsterdam

Publications: 53

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 51

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 49

Ferry Hagen

Ferry Hagen

Utrecht University

Publications: 45

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 42

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 41

Emilia Mellado

Emilia Mellado

Instituto de Salud Carlos III

Publications: 41

Trending Scientists

Christian Leuz

Christian Leuz

University of Chicago

Anatoliy A. Savchenkov

Anatoliy A. Savchenkov

OEwaves (United States)

Siegfried E. Vlaeminck

Siegfried E. Vlaeminck

University of Antwerp

Edward R. Grant

Edward R. Grant

University of British Columbia

Jannie S.J. van Deventer

Jannie S.J. van Deventer

University of Melbourne

Marcel M.A.M. Mannens

Marcel M.A.M. Mannens

University of Amsterdam

Jorge A. Meave

Jorge A. Meave

National Autonomous University of Mexico

Michael Tobler

Michael Tobler

Kansas State University

Andrew B. Tobin

Andrew B. Tobin

University of Glasgow

Damien Delvaux

Damien Delvaux

Royal Museum for Central Africa

Kazuhisa Goto

Kazuhisa Goto

University of Tokyo

Neil A. Rector

Neil A. Rector

Sunnybrook Health Science Centre

Zoltan Dienes

Zoltan Dienes

University of Sussex

Yuzhuo Wang

Yuzhuo Wang

University of British Columbia

Robert E. Mann

Robert E. Mann

Centre for Addiction and Mental Health

Raymond F. Palmer

Raymond F. Palmer

The University of Texas Health Science Center at San Antonio

Something went wrong. Please try again later.